Your browser doesn't support javascript.
loading
An update on treatment options for primary sclerosing cholangitis.
Iravani, Shahrokh; Dooghaie-Moghadam, Arash; Razavi-Khorasani, Niloofar; Moazzami, Bobak; Dowlati Beirami, Amirreza; Mansour-Ghanaei, Alireza; Majidzadeh-A, Keivan; Mehrvar, Azim; Khoshdel, Alireza; Nasiri Toosi, Mohssen; Sadeghi, Amir.
Afiliação
  • Iravani S; Research Center for Cancer Screening and Epidemiology, AJA University of Medical Sciences, Tehran, Iran.
  • Dooghaie-Moghadam A; Gastroenterology and Hepatobiliary Research Center, AJA University of Medical Sciences, Tehran, Iran.
  • Razavi-Khorasani N; Liver Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Moazzami B; Liver Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Dowlati Beirami A; Liver Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Mansour-Ghanaei A; Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Majidzadeh-A K; Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Mehrvar A; Research Center for Cancer Screening and Epidemiology, AJA University of Medical Sciences, Tehran, Iran.
  • Khoshdel A; Research Center for Cancer Screening and Epidemiology, AJA University of Medical Sciences, Tehran, Iran.
  • Nasiri Toosi M; Research Center for Cancer Screening and Epidemiology, AJA University of Medical Sciences, Tehran, Iran.
  • Sadeghi A; Liver Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Gastroenterol Hepatol Bed Bench ; 13(2): 115-124, 2020.
Article em En | MEDLINE | ID: mdl-32308932
ABSTRACT
Primary sclerosing cholangitis is a chronic cholestatic liver disease defined by strictures of the biliary tree which could ultimately lead to liver cirrhosis and cholangiocarcinoma. Although the exact underlying etiology of this disorder is not fully understood, the pathology is believed to be caused by immune mediated mechanisms. Growing body of evidence suggests several treatment modalities mainly focusing on the inflammation aspect of this disorder. However, there is still no consensus regarding the best treatment option for these patients. Thus, the present study aimed to review the current treatment options for patients with primary sclerosing cholangitis.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article